Advertisement

Who Is Keeping Tabs? LSD Lessons from the Past for the Future

  • Erika DyckEmail author
Chapter

Abstract

Psychedelics fell from medical grace nearly half a century ago, but recent activity suggests that some researchers are optimistic about their return. Are they at risk, however, of facing the same historic challenges with a new generation of psychedelic enthusiasts, or have the circumstances changed sufficiently to allow for a new path forward? The twenty-first-century incarnation of psychedelic research resurrects some anticipated hypotheses and explores some of the same applications that clinicians experimented with 50 years ago. On the surface then, the psychedelic renaissance might be dismissed for retreading familiar ground. A deeper look at the context that gave rise to these questions, though, suggests that while some of the questions are common, the culture of neuroscience and the business of drug regulation have changed sufficiently to warrant a retrial. A close look at the history of psychedelics encourages us to think carefully about the roles of regulators, the enthusiasm of researchers, and our cultural fascination and/or repulsion with mind-altering molecules.

References

  1. Aaronson, B., & Osmond, H. (Eds.). (1970). Psychedelics: The uses and implications of hallucinogenic drugs. Garden City, NY: Anchor.Google Scholar
  2. Abramson, H. (1960). The use of LSD in psychotherapy: Transactions of a conference on d-Lysergic Acid Diethylamide (LSD-25). Princeton, NJ: Josiah Macy Foundation.Google Scholar
  3. DeGrandpre, R. (2006). The cult of pharmacology: How America became the world’s most troubled drug culture. Durham, NC: Duke University Press.CrossRefGoogle Scholar
  4. Dodgson, R. (2013). It’s all a kind of magic: The young Ken Kesey. Madison: University of Wisconsin Press.Google Scholar
  5. Dyck, E. (2006). Hitting highs at rock bottom: LSD treatment for alcoholism, 1950–1970. Social History of Medicine, 19(2), 313–330.CrossRefGoogle Scholar
  6. Dyck, E. (2008). Psychedelic psychiatry: LSD from clinic to campus. Baltimore, MD: Johns Hopkins University Press.Google Scholar
  7. Dyck, E. (2011). “Just Say Know”: Criminalizing LSD and the politics of psychedelic expertise, 1961–8. In E. Montigny (Ed.), The real dope: Social, legal, and historical perspectives on the regulation of drugs in Canada (pp. 169–196). Toronto: University of Toronto Press.Google Scholar
  8. Dyck, E., & Bradford, T. (2012). Peyote on the prairies: Religion, scientists and Native-newcomer relations in western Canada. Journal of Canadian Studies, 46(1), 2852.CrossRefGoogle Scholar
  9. Dyck, E. (2012). The psychedelic sixties in North America: Drugs and identity. In L. Campbell, D. Clément, & G. S. Kealey (Eds.), Debating dissent: Canada and the sixties (pp. 47–66). Toronto: University of Toronto Press.Google Scholar
  10. Elcock, C. (2015). High New York: The birth of a psychedelic subculture in the American City (Doctoral dissertation). Saskatchewan, University of Saskatchewan.Google Scholar
  11. Ellwood, R. S. (1994). The sixties spiritual awakening: American religion moving from modern to postmodern. New Brunswick, N.J: Rutgers University Press.Google Scholar
  12. End the Ban on Psychoactive Drug Research [Editorial]. (2014). Scientific American, 310(2), 33. Retrieved from: http://www.scientificamerican.com/article/end-the-ban-on-psychoactive-drug-research/.Google Scholar
  13. Fuller, R. C. (2000). Stairways to heaven: Drugs in American religious history. Boulder, CO: Westview.Google Scholar
  14. Greenfield, R. (2006). Timothy Leary: A biography. Orlando, FL: Harcourt.Google Scholar
  15. Healy, D. (2004). Let them eat Prozac: The unhealthy relationship between the pharmaceutical industry and depression. New York City, NY: New York University Press.Google Scholar
  16. Henderson, S. (2011). Making the scene: Yorkville and hip Toronto in the 1960s. Toronto: University of Toronto Press.Google Scholar
  17. Hoffer, A., & Osmond, H. (1967). The hallucinogens. New York City, NY: Academic.Google Scholar
  18. Hofmann, A. (2013). LSD: My problem child and insights/outlooks. New York City, NY: Oxford University Press. (Original work published in 1980 as LSD: My problem child.)Google Scholar
  19. Jonnes, J. (1996). Hep-cats, narcs, and pipe dreams: A history of America’s romance with illegal drugs. Baltimore, MD: Johns Hopkins University Press.Google Scholar
  20. Kesey, K. (1962). One flew over the cuckoo’s nest. New York City, NY: Viking Press.Google Scholar
  21. Kingston, A. (2017, April 28). Canada’s science minister speaks out on women in STEM. MacLean’s. Retrieved from http://www.macleans.ca/society/canadas-science-minister-speaks-out-on-women-in-stem/
  22. Krebs, T., & Johansen, P. (2012). Lysergic acid diethylamide (LSD) for alcoholism: A meta-analysis of randomized controlled trials. Journal of Psychopharmacology, 25, 1–9.Google Scholar
  23. Labate, B. C., & Cavnar, C. (2016). Peyote: History, tradition, politics, and conservation. Santa Barbara, CA: Praeger.Google Scholar
  24. Langlitz, N. (2013). Neuropsychedelia: The revival of hallucinogen research since the decade of the brain. Berkley: University of California Press.Google Scholar
  25. Loder, N. (1999, November 25). Gender discrimination “undermines science.” Nature: News, 402. Retrieved from: https://www.nature.com/nature/journal/v402/n6760/full/402337a0.html
  26. Mangini, M. (1998). Treatment of alcoholism using psychedelic drugs: A review of the program of research. Journal of Psychoactive Drugs, 30(4), 381–418.CrossRefGoogle Scholar
  27. Marks, H. M. (1997). The progress of experiment: Science and therapeutic reform in the United States, 1900–1990. Cambridge, UK: Cambridge University Press.Google Scholar
  28. Maroukis, T. (2010). The peyote road: Religious freedom and the Native American Church. Norman, OK: University of Oklahoma Press.Google Scholar
  29. Maté, G. (2009). In the realm of hungry ghosts: Close encounters with addiction. Berkeley, CA: North Atlantic Books.Google Scholar
  30. Miller, T. (1991). The hippies and American values. Knoxville, TN: University of Tennessee.Google Scholar
  31. Mithoefer, M. C., Wagner, M. T., Mithoefer, A. T., Jerome, L., & Doblin, R. (2011). The safety and efficacy of ±3, 4-methylenedioxymethamphetamine-assisted psychotherapy in subjects with chronic, treatment-resistant posttraumatic stress disorder: The first randomized controlled pilot study. Journal of Psychopharmacology, 25(4), 439–452.CrossRefGoogle Scholar
  32. Nutt, D., King, L. A., Saulsbury, W., & Blakemore, C. (2007). Development of a rational scale to assess the harm of drugs of potential misuse. The Lancet, 369, 1047–1053.CrossRefGoogle Scholar
  33. Oram, M. (2014). Efficacy and enlightenment: LSD psychotherapy and the drug amendments of 1962. Journal for the History of Medicine and Allied Sciences, 69(2), 221–250.CrossRefGoogle Scholar
  34. Oram, M. (2016). Prohibited or regulated? LSD psychotherapy and the United States Food and Drug Administration. History of Psychiatry, 27(3), 290–306.CrossRefGoogle Scholar
  35. Oram, M. (2018). The trials of psychedelic therapy: LSD psychotherapy in the United States. Baltimore, MD: Johns Hopkins University Press.Google Scholar
  36. Osmond, H. (1957). A review of the clinical effects of psychotomimetic agents. Annals of The New York Academy of Sciences, 66(3), 418–434.CrossRefGoogle Scholar
  37. Osmond, H. (1967, February 9). Letter to Jonathan Cole, Chief, Psychopharmacology Service Centre, National Institute of Health. Provincial Archives of Saskatchewan. A207, XVIII, 20. B.Google Scholar
  38. Rouhier, A. (1927). Le Peyotl: La plante qui fait les yeux émerveillés [Peyote: The plant that amazes the eyes]. Paris, G. Doin.Google Scholar
  39. Rose, N. (2003). Neurochemical selves. Society, 41(1), 46–59.CrossRefGoogle Scholar
  40. Ross, S. (2012). Serotonergic hallucinogens and emerging targets for addiction pharmacotherapies. Psychiatric Clinics, 35(2), 357–374.PubMedGoogle Scholar
  41. Schneider, E. (2008). Smack: Heroin and the American city. Philadelphia: University of Pennsylvania Press.CrossRefGoogle Scholar
  42. Schwartz. C. (2017, May 6). Molly at the Marriott: Inside America’s premier psychedelics conference. The New York Times. Retrieved from https://www.nytimes.com/2017/05/06/style/psychedelic-drug-resurgence-daily-life.html?mcubz=1
  43. Spisak, J., with Cynthia, Bisbee, P., Dyck, E., Farrell, P., & Sexton, J. (2018). Psychedelic Prophets: The letters of Aldous Huxley and Humphry Osmond. Montreal: McGill-Queen’s University Press.Google Scholar
  44. Stevens, J. (1987). Storming Heaven: LSD and the American Dream. New York City, NY: Grove Press.Google Scholar
  45. Symons, A. (2015). Aldous Huxley’s hands: His quest for perception and the origin and return of psychedelic science. Amherst: NY. Prometheus Books.Google Scholar
  46. Wolfson, P. (2011). Psychedelics, spirituality, and transformation. Tikkun, 26(1), 10–88.CrossRefGoogle Scholar
  47. Zippel, K. (2017). Women in global science: Advancing academic careers through international collaboration. Palo Alto, CA: Stanford University Press.Google Scholar

Copyright information

© Springer International Publishing AG, part of Springer Nature 2018

Authors and Affiliations

  1. 1.Department of HistoryUniversity of SaskatchewanSaskatoonCanada

Personalised recommendations